The $300 price target has emerged as a closely watched milestone for Enova International, Inc. (ENVA) after S&P Global's survey of equity analysts identified it as the highest 12-month forecast among those covering the stock. With ENVA shares closing at $237.27 on July 24 and trading within striking distance of their 52-week high of $246.38, the $300 level represents a psychologically significant round number that would mark a roughly 26% gain from current levels. Several major firms — including Jefferies at $280, Citizens JMP at $270, and TD Cowen at $257 — have lifted their targets substantially following the company's better-than-expected second-quarter earnings, though none has yet crossed the $300 threshold. The question investors are now asking is whether continued momentum in small-business lending and the pending Grasshopper Bancorp acquisition can propel the stock past even the most optimistic Street estimates.
Enova International is a Chicago-based online financial services company that uses proprietary data analytics and machine learning to underwrite consumer and small-business loans for borrowers often underserved by traditional banks. Founded in 2004 and publicly traded since 2014, the company has originated more than $72 billion in loans and served over 15 million customers through brands including CashNetUSA, NetCredit, OnDeck, Headway Capital, and Pangea. The business operates two core segments: consumer lending, which generated $477 million in Q2 2026 revenue, and small and medium-sized business (SMB) lending, which delivered $439 million — up 35% year over year and now accounting for approximately 70% of the total loan portfolio.
The most powerful catalyst on the horizon is the pending acquisition of Grasshopper Bancorp, a digital bank with a national charter, in a cash-and-stock transaction valued at approximately $369 million. Management expects the deal to close in the second half of 2026 and projects it will be more than 25% accretive to adjusted earnings per share (EPS) once synergies are fully realized, alongside $175 million to $230 million in annual revenue synergies within two years. A bank charter would also lower Enova's funding costs — the cost of funds already declined to 8.1% in Q2 from 8.8% a year earlier — while expanding the product suite and geographic reach.
Organic growth remains robust even without the Grasshopper contribution. Q2 2026 adjusted EPS of $4.31 crushed the $3.96 consensus estimate, marking the eighth consecutive quarter of at least 30% year-over-year EPS growth. Consolidated originations rose 27%, extending an 11-quarter streak of at least 20% growth. The consolidated net charge-off ratio improved to 7.3% from 8.1% a year ago, signaling better credit quality. Management raised full-year 2026 guidance to 20%–25% revenue growth and 30%–35% adjusted EPS growth — figures that notably exclude any contribution from Grasshopper.
From a valuation standpoint, the stock trades at approximately 12.1 times consensus 2027 adjusted EPS with a price-to-earnings-growth (PEG) ratio of just 0.37, well below comparable small-cap financial indices. If sustained earnings momentum compresses the PEG ratio further or the market assigns a higher multiple as the bank charter reduces the risk profile, a move toward $300 becomes mathematically achievable. At a P/E of 15 times the consensus 2027 EPS estimate — roughly in line with the broader small-cap financial sector — the stock would already trade near $290 to $300.
Enova's debt profile is the most frequently cited risk by cautious analysts. Long-term debt stood at $4.83 billion as of March 31, 2026, against roughly $1.1 billion in total liquidity including cash, marketable securities, and available facility capacity. A debt-to-equity ratio above 3.4 leaves limited balance-sheet flexibility if the credit cycle turns. While the current net charge-off ratio of 7.3% is improving, it remains elevated in absolute terms and reflects the inherent risk of lending to nonprime borrowers — a customer base that would be among the first to feel pressure in an economic downturn.
Regulatory risk also deserves attention. Enova operates in a heavily scrutinized corner of consumer finance, and any tightening of rules around nonprime lending, interest rate caps, or fintech oversight could compress revenue margins and slow origination growth. The Grasshopper deal itself requires regulatory approval, and any delay or adverse condition attached to the closing could undermine the synergy assumptions currently supporting higher analyst price targets.
Additionally, the stock has already rallied more than 112% over the past 12 months and roughly 42% in the last 90 days. With the consensus analyst target clustered around $247 to $255, the market already prices in considerable optimism. Some fair-value models, including those published by Simply Wall St, place intrinsic value near $230 — slightly below the current share price — suggesting that further upside depends heavily on flawless execution rather than multiple expansion alone.
The weekly chart shows a well-defined uptrend with accelerating momentum following the Q2 earnings release. Support has solidified near the $220–$223 area, where dip-buyers stepped in aggressively after a brief pullback from the $230 level. The 52-week high of $246.38 is the immediate resistance zone; a weekly close above that level would confirm a breakout from the multi-month consolidation range and open a pathway toward the $260–$270 zone, where the next concentration of analyst targets sits. The 200-day moving average near $169 provides a distant but structurally important floor. From a supply-and-demand perspective, $300 represents a round-number psychological barrier that has no prior trading history, meaning it would be uncharted territory and could attract profit-taking.
Wall Street remains broadly constructive on ENVA. Of nine analysts covering the stock, eight rate it a Buy or equivalent, and one maintains a Hold. The consensus 12-month price target stands near $247, with individual targets ranging from $200 (Maxim Group) to $300 (the highest estimate in S&P Global's survey). Jefferies raised its target to $280 in early July, while Citizens JMP moved to $270 in late June, both citing the earnings power unlocked by the Grasshopper acquisition. TD Cowen lifted its target to $257 following the Q2 beat. While no major firm has officially published a $300 target, the upward trajectory of analyst revisions — the consensus target has climbed from $111 one year ago to nearly $247 today — suggests that a $300 target could enter mainstream analyst coverage if the Grasshopper deal closes on schedule and synergies begin to materialize.
For traders looking to stay ahead of rapid shifts in market sentiment, Tickeron's AI Daily Buy/Sell Signals offer a data-driven approach to monitoring stocks like Enova International. The platform uses artificial intelligence to continuously scan thousands of equities and ETFs, generating real-time Buy, Sell, or Hold signals based on evolving technical patterns, market conditions, and AI-powered analysis. Rather than manually tracking every price movement, traders can use these signals to identify emerging opportunities, manage existing positions more efficiently, and spot trend changes before they become obvious to the broader market. Exploring the AI Daily Buy/Sell Signals product can help investors integrate machine-driven insights into their own decision-making process.
The case for Enova International reaching $300 is built on a foundation of undeniable operational momentum: 27% origination growth, 33% adjusted EPS expansion, improving credit metrics, and a transformational bank acquisition that could meaningfully lower funding costs and expand the addressable market. If the Grasshopper deal closes on schedule and delivers the 25%-plus EPS accretion management has projected, the earnings base could easily support a stock price in the $280–$300 range, particularly if the market rewards the lower risk profile of a bank-chartered entity with a higher valuation multiple. The stock's PEG ratio near 0.37 suggests it remains inexpensive relative to its growth rate even after a powerful rally.
However, the risks are equally real: elevated leverage, exposure to nonprime borrowers, regulatory uncertainty, and a share price that already reflects considerable optimism. A deterioration in credit performance, a delay in the Grasshopper closing, or a broader economic slowdown could quickly challenge the earnings trajectory that underpins the bull case. Investors should monitor quarterly charge-off trends, the Grasshopper regulatory approval process, and management's ability to sustain origination growth above 20% without sacrificing credit quality. While $300 is not the base case for most analysts, it is within reach if Enova continues executing at its current pace and the macroeconomic environment remains supportive. Whether it gets there depends less on hope and more on the hard numbers of credit performance and acquisition integration in the quarters ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Disclaimers and LimitationsA.I.dvisor indicates that over the last year, ENVA has been closely correlated with ALLY. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if ENVA jumps, then ALLY could also see price increases.
| Ticker / NAME | Correlation To ENVA | 1D Price Change % | ||
|---|---|---|---|---|
| ENVA | 100% | +8.94% | ||
| ALLY - ENVA | 69% Closely correlated | -2.39% | ||
| URI - ENVA | 68% Closely correlated | +0.16% | ||
| R - ENVA | 68% Closely correlated | -0.09% | ||
| OMF - ENVA | 63% Loosely correlated | +1.63% | ||
| COF - ENVA | 63% Loosely correlated | +1.44% | ||
More | ||||
| Ticker / NAME | Correlation To ENVA | 1D Price Change % |
|---|---|---|
| ENVA | 100% | +8.94% |
| Savings Banks industry (54 stocks) | 72% Closely correlated | +0.01% |
| Banks industry (433 stocks) | 66% Closely correlated | +0.72% |
| ENVA industry (4 stocks) | 32% Poorly correlated | +1.66% |